Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpubmed.ncbi.nlm.nih.gov
Moga Rash
Get the latest updates from Moga Rash directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 3 years ago
Mogamulizumab-associated rash simulating Lupus miliaris disseminatus faciei
over 3 years ago
J Eur Acad Dermatol Venereol. 2022 Nov 15. doi: 10.1111/jdv.18741. Online ahead...
Scarring alopecia developing after mogamulizumab-associated rash
over 4 years ago
Eur J Dermatol. 2021 Dec 1;31(6):841-843. doi: 10.1684/ejd.2021.4179.NO ABSTRACTPMID:35107074 | DOI:10.1684/ejd.2021.4179
Head and Neck granulomatous Rash Associated with Mogamulizumab Mimicking Mycosis Fungoides
over 4 years ago
Br J Dermatol. 2022 Jan 26. doi: 10.1111/bjd.21030. Online ahead of print.NO...
Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral E-cell lymphoma
over 4 years ago
JAAD Case Rep. 2021 Dec 15;20:44-46. doi: 10.1016/j.jdcr.2021.11.022. eCollection 2022 Feb.NO ABSTRACTPMID:35036504...
Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma
over 4 years ago
Br J Dermatol. 2022 Jan;186(1):15-16. doi: 10.1111/bjd.20821. Epub 2021 Nov 2.NO ABSTRACTPMID:34988981...
Macrophage-derived CXCL9 and CXCL11, T-cell skin homing and disease control in mogamulizumab-treated CTCL patients
over 4 years ago
Blood. 2021 Dec 14:blood.2021013341. doi: 10.1182/blood.2021013341. Online ahead of print.ABSTRACTCutaneous T-cell lymphoma...
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
over 4 years ago
Dermatol Ther (Heidelb). 2021 Nov 23. doi: 10.1007/s13555-021-00624-7. Online ahead of print.ABSTRACTThe...
Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
almost 5 years ago
Eur J Cancer. 2021 Oct;156 Suppl 1:S46. doi: 10.1016/S0959-8049(21)00712-7.NO ABSTRACTPMID:34649656 | DOI:10.1016/S0959-8049(21)00712-7
Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series
almost 5 years ago
Eur J Cancer. 2021 Oct;156 Suppl 1:S49. doi: 10.1016/S0959-8049(21)00716-4.NO ABSTRACTPMID:34649659 | DOI:10.1016/S0959-8049(21)00716-4
Mogamulizumab Efficacy is Underscored by its Associated Rash that Mimics Cutaneous T-cell Lymphoma: A Retrospective Single-Centre Case Series
almost 5 years ago
Br J Dermatol. 2021 Aug 24. doi: 10.1111/bjd.20708. Online ahead of print.ABSTRACTBACKGROUND...
Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
about 5 years ago
JAAD Case Rep. 2021 Jun 9;14:37-42. doi: 10.1016/j.jdcr.2021.05.037. eCollection 2021 Aug.NO ABSTRACTPMID:34258350...
Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies
about 5 years ago
BMC Cancer. 2021 May 26;21(1):618. doi: 10.1186/s12885-021-08363-w.ABSTRACTBACKGROUND: CC chemokine receptor 4 (CCR4)...